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Febrile seizures are the most common type of convulsions. Medicinal 
prophylaxis is sometimes used for children at high risk of recurrent febrile 
seizure. In certain circumstances, conventional drugs such as diazepam and 
phenobarbital cannot be used and the need for alternative medicines is felt. This 
study compared the effectiveness of topiramate and diazepam in preventing 
the risk of recurrent febrile seizure in children under 2 yr old.
Materials and Methods
This randomized controlled trial, in Besat Hospital in Hamedan, Iran 
from 22 Nov 2013 to 22 Nov 2015 (Registered code: IRCT Number: 
IRCT2015010120527N1), included 54 patients, at risk of recurrent febrile 
seizure, inhibited from taking phenobarbital. Samples were randomly divided 
into two groups. The first group received diazepam treatment during fever 
episodes and the second group received daily dose of topiramate. A one-year 
follow-up of recurrent febrile seizure and its complications was also conducted.
Results
Thirty-four patients (17 patients in each group) completed the one-year 
course of the trial. Recurrent febrile seizure was not observed in the course of 
preventive treatment. The prevalence of minor complications was 29.4% in the 
diazepam group and 48.5% in the topiramate group. No major complication 
was observed in among the subjects
Conclusion
Topiramate can be recommended for preventing recurrent febrile seizure when 
the use of frontline medicines is not possible.
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Introduction 
Febrile seizure is the most common type of convulsion in childhood with 
the prevalence of 2% - 5% among children between the ages of 6 and 60 
months (1-3). The prevalence of febrile seizure is higher in some regions 
(e.g. 9%-10% in Japan versus 14% in the Mariana Islands in Guam) (2). 
About 21% of seizure attacks happen before or within 1 h after the onset of 
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seizure management (2). Sometimes a preventive 
treatment is given to a child with a febrile seizure, 
owing to the incidence of prolonged seizures, 
parental anxiety, and the hard-to-access medical 
centers (6). There are currently 3 major recurrent 
febrile seizure prevention techniques: (i) daily 
dose of oral phenobarbital, (ii) daily dose of oral 
sodium valproate, and (iii) oral diazepam during 
fever episodes. Each of these methods has its own 
strengths and weaknesses (7-9).
 Phenobarbital is an effective medicine for the 
prevention of a recurrent febrile seizure when its 
serum concentration reaches15 µg/mL. The intake 
of phenobarbital has decreased yearly incidence 
of 25 types of seizures to five (3, 10). However, 
such complications as allergic reactions, as well 
as cognitive and behavioral disorders are widely 
observed in these patients (20%-40%) (3). On a 
yearly average, the use of diazepam during fever 
episodes decreases the incidence risk of febrile 
seizure by 44% (ibid). However, the administration 
of diazepam is challenging for parents because 
they have to measure the child’s body temperature 
regularly. In addition, there is a risk of an anti-
fever seizure (21%). Moreover, diazepam may be 
associated with such complications as restlessness, 
balance disorders, irritability and drowsiness (10-
12). Daily dose of sodium valproate is effective 
in febrile seizure management, with 4% risk for 
recurrence versus 35% in control group per year 
(3). In some circumstances, physicians decide 
to administer prophylactic therapy for a child 
having febrile seizure, but the use of conventional 
medicines is not possible. For example, 
phenobarbital-induced allergy and recurrent febrile 
seizure in early hours after the onset of fever in a 
neonate inhibit prophylaxis with benzodiazepines. 
fever, and only 22% occur more than 24 h after the 
onset of fever (2). 
Almost one-third of all children with febrile 
seizures will have a recurrence. Age is the main 
risk factor of the recurrence with 50% probability 
under the age of 1 year. The first recurrence after 
an initial febrile seizure usually occurs within a 
year of the initial seizure. A first-degree family 
history positive for febrile seizures increases the 
risk of a recurrence. In addition, children who 
have an initial seizure with a low-grade fever are 
more prone to a recurrence (3, 4). Simple febrile 
seizures are a benign phenomenon not associated 
with increased rate of mortality, and cognitive and 
cerebral complications (3, 5). 
The risk of epilepsy in people at 25 yr with a 
history of simple febrile seizure after age 1 year 
is as high as normal people (1%). The risk of 
developing epilepsy in children with an initial 
febrile seizure before age 1 year and with family 
history positive for epilepsy is 24% at age 25 (3). 
On the other hand, scant evidence of cerebral 
traumas has been observed among patients with a 
history of a prolonged febrile seizure. According 
to magnetic resonance imaging examinations of 
the brain, acute brain changes have been observed 
in 30%-40% of children with a prolonged febrile 
seizure (90-100 min) (5). Forty percent of people 
with mesial temporal epilepsy had a history of 
prolonged seizures in childhood (2).
 Concerning the benign nature of febrile seizures 
in most cases, the main goal of treating such 
patients is to prevent the incidence of a prolonged 
seizure. To this end, diazepam is given rectally at 
home or during transfer to hospital; in addition, 
anticonvulsant medications are used in hospital for 
 Comparison of Effectiveness of Topiramate and Diazepam in Preventing Risk of Recurrent Febrile Seizure...


73Iran J Child Neurol. Summer 2018 Vol. 12 No. 3
 Comparison of Effectiveness of Topiramate and Diazepam in Preventing Risk of Recurrent Febrile Seizure...
Among the patients, 10 subjects were female and 
24 subjects were male. In terms of age, 61.8% of 
subjects were older than 12 months and 38.2% 
were 12-month old or younger. In addition, 67.6% 
and 32.4% of subjects developed simple febrile 
seizure and complex febrile seizure, respectively. 
The two groups were compared in terms of age, 
sex, type of seizure, number of recurrent risk 
factors (criteria for receiving preventive therapy), 
and family history positive for epilepsy, fever, and 
seizure. There was no significant between-group 
difference in these factors (P>0.05) (Table 1).
Seizure recurrence was not observed in the patients 
in the following year. Certainly, the two groups 
would not be different in the rate of recurrent 




Ratio of patients ≤ 12 months to patients >12 months 0.88 0.416 0.290
Ratio of boys to girls 2.4 2.4 1.00
Seizure type (ratio of simple to complex seizures) 1.83 2.4 0.714
Mean number of risk factors for recurrent seizure 2.76 2.74 0.301
Family history positive for epilepsy (ratio of people with and 
without family history)
21.42 21.42 1.00
Family history positive for fever and seizure (ratio of people 
with and without family history)
0.7 0.307 0.271
febrile seizure.
In the diazepam group, 3 subjects developed 
significant drowsiness and 2 subjects developed 
balance disorder (29.4% in total). In the topiramate 
group, 4 cases developed mild skin rashes, 4 
subjects developed irritability, 2 subjects had fever, 
and 1 subject developed anorexia (45.8% in total) 
(P=0.008). In general, a major complication was 
not observed in any of the patients (Figure 2).
Discussion
In our study, none of the patients receiving 
preventive therapy with diazepam developed 
recurrent febrile seizure. The effectiveness 
of taking diazepam during fever episodes for 
controlling febrile seizure is reported (3). The lack 
of difference between the outcomes of diazepam 
and topiramate therapies in our study may indicate 
the effectiveness of topiramate in preventing the 
incidence of febrile seizure. Topiramate could be 
used for the prevention of recurrent febrile seizure 
owing to its protective effect on blood-brain barrier 
(16). Children with probable risk of recurrent febrile 
seizure or epilepsy received monotherapy with 
topiramate and a 10-yr follow-up, during which 
no seizure recurrence was reported. The early use 
of topiramate (as an antiepilepsy drug) was very 
effective for children at risk of recurrent febrile 
seizure (15). The protective effect of topiramate 
on neurons) could prevent the development of 
hippocampal sclerosis and symptomatic epilepsy 
in children with recurrent febrile seizure (17). 
The prevalence of 10% to 20% was reported for 
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complications. Despite this, the prevalence of 11%-
56% was reported for topiramate complications; 
whereas, some of these complications were 
observed in less than half of our subjects (28-31). 
In conclusion, despite having mild complications, 
topiramate can be used as an alternative medicine 
for children with a high risk of recurrent febrile 
seizure, when phenobarbital and diazepam cannot 
be used. For having fewer complications, daily 
dose of diazepam during fever episodes is a better 
choice; however, it is not adequately efficient in the 
early hours after the onset of fever and or for low-
grade fevers. Further studies are recommended to 
compare topiramate with other medicines such as 
phenobarbital, using a larger sample size.
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